Publication:
A randomized, placebo-controlled phase I trial of DNA prime, recombinant fowlpox virus boost prophylactic vaccine for HIV-1
A randomized, placebo-controlled phase I trial of DNA prime, recombinant fowlpox virus boost prophylactic vaccine for HIV-1
| dc.contributor.author | Kelleher, Anthony | en_US |
| dc.contributor.author | Puls, Rebekah | en_US |
| dc.contributor.author | Bebbington, M | en_US |
| dc.contributor.author | Boyle, D | en_US |
| dc.contributor.author | Kent, S | en_US |
| dc.contributor.author | Kippax, Susan | en_US |
| dc.contributor.author | Purcell, D | en_US |
| dc.contributor.author | Thomson, S | en_US |
| dc.contributor.author | Wand, Handan | en_US |
| dc.contributor.author | Cooper, David | en_US |
| dc.contributor.author | Emery, Sean | en_US |
| dc.contributor.author | Ffrench, R | en_US |
| dc.date.accessioned | 2021-11-25T15:06:10Z | |
| dc.date.available | 2021-11-25T15:06:10Z | |
| dc.date.issued | 2006 | en_US |
| dc.description.abstract | An HIV-vaccine consisting of a DNA prime, recombinant fowlpox virus (rFPV) boost was evaluated in a double-blind placebo controlled trial. One milligram of pHIS-HIV-B expressing mutated gag, pol, env, vpu, tat and rev was administered at weeks 0 and 4 boosted by 5 X 10(7) \pfu rFPV-HIV-B expressing gag/pol at week 8. The vaccine regimen was safe, but there was no difference between vaccine (n = 18) and placebo recipients (n = 6) for Gag or Pol-specific T-cell immune responses at week 9. | en_US |
| dc.identifier.issn | 0269-9370 | en_US |
| dc.identifier.uri | http://hdl.handle.net/1959.4/44142 | |
| dc.language | English | |
| dc.language.iso | EN | en_US |
| dc.rights | CC BY-NC-ND 3.0 | en_US |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/3.0/au/ | en_US |
| dc.source | Legacy MARC | en_US |
| dc.title | A randomized, placebo-controlled phase I trial of DNA prime, recombinant fowlpox virus boost prophylactic vaccine for HIV-1 | en_US |
| dc.type | Journal Article | en |
| dcterms.accessRights | metadata only access | |
| dspace.entity.type | Publication | en_US |
| unsw.accessRights.uri | http://purl.org/coar/access_right/c_14cb | |
| unsw.relation.faculty | Medicine & Health | |
| unsw.relation.faculty | Arts Design & Architecture | |
| unsw.relation.ispartofissue | 2 | en_US |
| unsw.relation.ispartofjournal | AIDS | en_US |
| unsw.relation.ispartofpagefrompageto | 294-297 | en_US |
| unsw.relation.ispartofvolume | 20 | en_US |
| unsw.relation.originalPublicationAffiliation | Kelleher, Anthony, National Centre in HIV Epidemiology & Clinical Research, Faculty of Medicine, UNSW | en_US |
| unsw.relation.originalPublicationAffiliation | Puls, Rebekah, National Centre in HIV Epidemiology & Clinical Research, Faculty of Medicine, UNSW | en_US |
| unsw.relation.originalPublicationAffiliation | Bebbington, M | en_US |
| unsw.relation.originalPublicationAffiliation | Boyle, D | en_US |
| unsw.relation.originalPublicationAffiliation | Kent, S | en_US |
| unsw.relation.originalPublicationAffiliation | Kippax, Susan, National Centre in HIV Social Research, Faculty of Arts & Social Sciences, UNSW | en_US |
| unsw.relation.originalPublicationAffiliation | Purcell, D | en_US |
| unsw.relation.originalPublicationAffiliation | Thomson, S | en_US |
| unsw.relation.originalPublicationAffiliation | Wand, Handan, National Centre in HIV Epidemiology & Clinical Research, Faculty of Medicine, UNSW | en_US |
| unsw.relation.originalPublicationAffiliation | Cooper, David, National Centre in HIV Epidemiology & Clinical Research, Faculty of Medicine, UNSW | en_US |
| unsw.relation.originalPublicationAffiliation | Emery, Sean, National Centre in HIV Epidemiology & Clinical Research, Faculty of Medicine, UNSW | en_US |
| unsw.relation.originalPublicationAffiliation | Ffrench, R | en_US |
| unsw.relation.school | The Kirby Institute | * |
| unsw.relation.school | Centre for Social Research in Health | * |